Augmedix Inc
NASDAQ:AUGX
Intrinsic Value
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. [ Read More ]
The intrinsic value of one AUGX stock under the Base Case scenario is 6.37 USD. Compared to the current market price of 4.09 USD, Augmedix Inc is Undervalued by 36%.
Valuation Backtest
Augmedix Inc
Run backtest to discover the historical profit from buying and selling AUGX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Augmedix Inc's business.
What risks and challenges
does Augmedix Inc face in the near future?
Summarize the latest earnings report
of Augmedix Inc.
Provide P/E
for Augmedix Inc and its competitors.
Balance Sheet Decomposition
Augmedix Inc
Current Assets | 33.1m |
Cash & Short-Term Investments | 21.6m |
Receivables | 9.5m |
Other Current Assets | 2m |
Non-Current Assets | 7.8m |
PP&E | 6.3m |
Other Non-Current Assets | 1.5m |
Current Liabilities | 24.7m |
Accounts Payable | 1.8m |
Accrued Liabilities | 6.5m |
Other Current Liabilities | 16.4m |
Non-Current Liabilities | 15.4m |
Long-Term Debt | 12.6m |
Other Non-Current Liabilities | 2.8m |
Earnings Waterfall
Augmedix Inc
Revenue
|
40.9m
USD
|
Cost of Revenue
|
-21.6m
USD
|
Gross Profit
|
19.3m
USD
|
Operating Expenses
|
-39.2m
USD
|
Operating Income
|
-19.9m
USD
|
Other Expenses
|
-420k
USD
|
Net Income
|
-20.3m
USD
|
Free Cash Flow Analysis
Augmedix Inc
What is Free Cash Flow?
AUGX Profitability Score
Profitability Due Diligence
Augmedix Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Augmedix Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
AUGX Solvency Score
Solvency Due Diligence
Augmedix Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Score
Augmedix Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AUGX Price Targets Summary
Augmedix Inc
According to Wall Street analysts, the average 1-year price target for AUGX is 6.92 USD with a low forecast of 5.96 USD and a high forecast of 8.4 USD.
Ownership
AUGX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
AUGX Price
Augmedix Inc
Average Annual Return | -43.53% |
Standard Deviation of Annual Returns | 11.77% |
Max Drawdown | -86% |
Market Capitalization | 198.6m USD |
Shares Outstanding | 48 555 200 |
Percentage of Shares Shorted | 2.62% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 706 full-time employees. The company went IPO on 2021-03-04. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and provides a suite of related services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automatic speech recognition and natural language processing and is overseen by trained medical documentation specialists (MDS). Augmedix provides service from approximately nine MDS operations centers across four countries: the United States, Bangladesh, India and Sri Lanka.
Contact
IPO
Employees
Officers
The intrinsic value of one AUGX stock under the Base Case scenario is 6.37 USD.
Compared to the current market price of 4.09 USD, Augmedix Inc is Undervalued by 36%.